Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

John Mitchell

Concepts (370)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pneumonectomy
34
2024
125
5.830
 Why?
Mycobacterium Infections, Nontuberculous
9
2023
333
2.960
 Why?
Esophageal Neoplasms
16
2023
273
2.460
 Why?
Lung Neoplasms
36
2024
2177
2.430
 Why?
Thoracic Surgery
12
2023
106
2.360
 Why?
Thoracic Surgical Procedures
12
2023
57
2.080
 Why?
Lung Diseases
7
2023
701
1.650
 Why?
Thoracic Surgery, Video-Assisted
10
2022
40
1.570
 Why?
Esophagectomy
13
2023
111
1.350
 Why?
Carcinoma, Non-Small-Cell Lung
14
2024
961
1.280
 Why?
Nontuberculous Mycobacteria
4
2023
204
1.190
 Why?
Bronchiectasis
3
2012
106
1.060
 Why?
Lung Transplantation
7
2019
246
1.030
 Why?
Tuberculosis, Pulmonary
3
2018
113
1.000
 Why?
Robotic Surgical Procedures
6
2024
85
0.990
 Why?
Postoperative Complications
20
2023
2128
0.970
 Why?
Empyema, Pleural
2
2015
11
0.940
 Why?
Anesthesiology
2
2022
35
0.920
 Why?
Societies, Medical
10
2023
664
0.910
 Why?
Adenocarcinoma
7
2021
795
0.880
 Why?
Neoplasm Staging
14
2024
1167
0.820
 Why?
Clinical Competence
7
2022
893
0.780
 Why?
Anesthesiologists
1
2021
11
0.740
 Why?
Education, Medical, Graduate
2
2021
368
0.710
 Why?
Humans
108
2024
114709
0.690
 Why?
Surgeons
4
2023
239
0.620
 Why?
Echocardiography, Transesophageal
3
2019
89
0.610
 Why?
Practice Guidelines as Topic
6
2017
1394
0.580
 Why?
Thoracic Wall
1
2017
14
0.560
 Why?
Tomography, X-Ray Computed
10
2018
2286
0.560
 Why?
Soft Tissue Infections
1
2017
30
0.550
 Why?
Abscess
1
2017
72
0.540
 Why?
Thoracoscopy
5
2020
57
0.540
 Why?
Bronchial Fistula
2
2015
4
0.530
 Why?
Respiratory Tract Fistula
2
2015
8
0.520
 Why?
Pleural Diseases
2
2015
20
0.520
 Why?
Internship and Residency
4
2022
926
0.510
 Why?
Pleura
1
2015
18
0.510
 Why?
Osteomyelitis
1
2017
105
0.500
 Why?
Thoracotomy
5
2019
75
0.490
 Why?
Pneumonia, Bacterial
2
2013
106
0.490
 Why?
Databases, Factual
12
2023
1126
0.490
 Why?
Curriculum
1
2021
819
0.480
 Why?
Minimally Invasive Surgical Procedures
5
2023
154
0.460
 Why?
Computer-Assisted Instruction
1
2014
62
0.450
 Why?
Chest Tubes
1
2013
30
0.440
 Why?
Equipment Contamination
1
2013
54
0.430
 Why?
Treatment Outcome
18
2023
9089
0.430
 Why?
Ischemic Preconditioning
2
2023
28
0.430
 Why?
Tracheobronchomalacia
1
2012
14
0.410
 Why?
Computer Simulation
4
2021
873
0.400
 Why?
Tuberculosis, Multidrug-Resistant
1
2012
46
0.390
 Why?
Sputum
1
2013
286
0.380
 Why?
Early Detection of Cancer
1
2015
328
0.380
 Why?
Female
51
2023
59571
0.370
 Why?
Coronary Artery Bypass
2
2015
196
0.370
 Why?
Mass Screening
2
2015
1006
0.370
 Why?
Male
46
2023
55667
0.360
 Why?
Anti-Bacterial Agents
4
2019
1482
0.360
 Why?
Middle Aged
38
2023
26740
0.360
 Why?
Pneumoperitoneum
1
2010
11
0.350
 Why?
Consensus
4
2021
539
0.350
 Why?
Laparoscopy
3
2023
398
0.350
 Why?
Conversion to Open Surgery
2
2020
14
0.350
 Why?
Trachea
3
2022
224
0.350
 Why?
Simulation Training
2
2021
61
0.340
 Why?
Combined Modality Therapy
6
2022
1121
0.340
 Why?
Aged
30
2023
19075
0.340
 Why?
Retrospective Studies
20
2023
12557
0.310
 Why?
Cost of Illness
1
2010
254
0.310
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2015
1356
0.310
 Why?
Specialties, Surgical
2
2023
70
0.300
 Why?
Anastomosis, Surgical
2
2023
136
0.300
 Why?
Small Cell Lung Carcinoma
2
2024
77
0.300
 Why?
United States
17
2023
12184
0.300
 Why?
Mycobacterium avium-intracellulare Infection
1
2008
63
0.280
 Why?
Diaphragm
2
2023
33
0.270
 Why?
Patient Satisfaction
1
2010
578
0.270
 Why?
Postoperative Care
3
2012
222
0.260
 Why?
Benchmarking
3
2023
161
0.260
 Why?
Airway Obstruction
2
2022
168
0.260
 Why?
Esophageal Diseases
1
2006
24
0.260
 Why?
Fever
1
2007
280
0.260
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.250
 Why?
Thoracic Neoplasms
1
2005
32
0.240
 Why?
Patient Readmission
3
2019
610
0.230
 Why?
Preoperative Care
3
2012
319
0.230
 Why?
Carcinoma, Bronchogenic
1
2003
17
0.220
 Why?
Interleukin-6
1
2007
676
0.220
 Why?
Respiratory Paralysis
1
2023
3
0.220
 Why?
Pleural Neoplasms
1
2003
18
0.220
 Why?
Length of Stay
5
2023
962
0.220
 Why?
Biomedical Research
2
2021
585
0.210
 Why?
Hypothermia
1
2023
38
0.210
 Why?
Propensity Score
3
2019
224
0.210
 Why?
Prognosis
8
2019
3330
0.210
 Why?
Plasmacytoma
1
2022
9
0.210
 Why?
Tracheal Neoplasms
1
2022
11
0.210
 Why?
Bronchi
2
2007
232
0.210
 Why?
Neoplasms, Second Primary
1
2024
92
0.210
 Why?
Pain, Postoperative
2
2023
191
0.200
 Why?
Anesthetics
1
2022
54
0.200
 Why?
Patient Selection
5
2015
641
0.200
 Why?
Aged, 80 and over
11
2020
6346
0.190
 Why?
Sarcoma
1
2003
137
0.190
 Why?
Leukemia
1
2024
209
0.190
 Why?
Adult
23
2023
30561
0.180
 Why?
Infectious Disease Transmission, Patient-to-Professional
1
2021
21
0.180
 Why?
Interdisciplinary Research
1
2021
25
0.180
 Why?
Developing Countries
1
2022
235
0.180
 Why?
Technology
1
2021
79
0.180
 Why?
Cardiovascular Diseases
3
2019
1728
0.180
 Why?
Education, Distance
1
2021
38
0.180
 Why?
Cardiovascular Abnormalities
1
2020
10
0.170
 Why?
Quality of Life
3
2024
2353
0.170
 Why?
Robotics
1
2021
75
0.170
 Why?
Bronchoscopy
4
2012
245
0.170
 Why?
Subclavian Artery
1
2020
29
0.170
 Why?
Carotid Artery, Common
1
2020
29
0.170
 Why?
Workflow
1
2021
133
0.170
 Why?
General Surgery
1
2021
127
0.170
 Why?
Pandemics
3
2023
1320
0.170
 Why?
Educational Measurement
1
2021
243
0.160
 Why?
Esophagogastric Junction
2
2021
42
0.160
 Why?
Anesthesia
1
2021
117
0.160
 Why?
Teaching
1
2021
213
0.160
 Why?
Metastasectomy
1
2018
13
0.160
 Why?
Carcinoma, Squamous Cell
3
2012
577
0.150
 Why?
Neoadjuvant Therapy
4
2022
304
0.150
 Why?
Pulmonary Emphysema
2
2015
272
0.150
 Why?
Negative-Pressure Wound Therapy
1
2017
14
0.140
 Why?
Pain Management
1
2020
288
0.140
 Why?
Learning
1
2021
350
0.140
 Why?
Forms and Records Control
1
2017
22
0.140
 Why?
Gastric Outlet Obstruction
1
2017
7
0.140
 Why?
Pylorus
1
2017
13
0.140
 Why?
Frailty
1
2019
115
0.140
 Why?
CD4-Positive T-Lymphocytes
2
2017
959
0.140
 Why?
Lymphocytes, Tumor-Infiltrating
1
2017
111
0.140
 Why?
NADPH Oxidases
1
2017
120
0.130
 Why?
Antigen Presentation
1
2017
188
0.130
 Why?
Neuromuscular Agents
1
2017
30
0.130
 Why?
Extracorporeal Membrane Oxygenation
1
2019
241
0.130
 Why?
Botulinum Toxins, Type A
1
2017
40
0.130
 Why?
Prospective Studies
7
2024
6220
0.130
 Why?
Disease-Free Survival
3
2023
620
0.130
 Why?
Cause of Death
1
2017
361
0.130
 Why?
Documentation
1
2017
167
0.120
 Why?
Survival Rate
4
2019
1644
0.120
 Why?
Patient-Centered Care
1
2020
473
0.120
 Why?
Chronic Disease
3
2017
1579
0.120
 Why?
Pulmonary Disease, Chronic Obstructive
2
2015
916
0.120
 Why?
Radiotherapy Dosage
1
2015
244
0.120
 Why?
Asphyxia
1
2014
21
0.120
 Why?
Diabetes Mellitus
1
2022
900
0.120
 Why?
Chemotherapy, Adjuvant
2
2005
332
0.110
 Why?
Intubation, Intratracheal
1
2016
216
0.110
 Why?
Risk
2
2015
812
0.110
 Why?
Dyspnea
2
2023
211
0.110
 Why?
Perfusion
1
2014
148
0.110
 Why?
Suture Techniques
2
2006
115
0.110
 Why?
Anastomotic Leak
2
2023
27
0.110
 Why?
Patient Discharge
1
2019
772
0.110
 Why?
Health Expenditures
1
2015
171
0.110
 Why?
Mutation
3
2022
3346
0.110
 Why?
Stomach
2
2023
102
0.100
 Why?
Carcinoma, Large Cell
1
2012
14
0.100
 Why?
Group II Phospholipases A2
1
2012
19
0.100
 Why?
Cardiac Surgical Procedures
2
2017
414
0.100
 Why?
Cardiology
1
2015
259
0.100
 Why?
Extensively Drug-Resistant Tuberculosis
1
2012
6
0.100
 Why?
Consumer Health Information
1
2013
47
0.100
 Why?
B-Lymphocytes
1
2017
766
0.100
 Why?
Radiography
1
2014
812
0.100
 Why?
Volatile Organic Compounds
1
2012
45
0.100
 Why?
Cost-Benefit Analysis
1
2015
544
0.100
 Why?
Tracheal Stenosis
1
2012
24
0.100
 Why?
ErbB Receptors
2
2022
554
0.100
 Why?
ras Proteins
1
2012
138
0.100
 Why?
Risk Assessment
4
2023
2968
0.100
 Why?
Logistic Models
4
2019
1841
0.090
 Why?
Smoking
2
2017
1383
0.090
 Why?
Quality Improvement
4
2020
950
0.090
 Why?
Patient Reported Outcome Measures
2
2024
250
0.090
 Why?
Cohort Studies
4
2019
4895
0.090
 Why?
Tissue and Organ Procurement
1
2014
228
0.090
 Why?
Physician's Role
1
2013
197
0.090
 Why?
Antitubercular Agents
1
2012
169
0.090
 Why?
Morbidity
3
2023
280
0.090
 Why?
Oxidative Stress
1
2017
1076
0.090
 Why?
Mycobacterium Infections
1
2011
61
0.090
 Why?
Hemoptysis
1
2010
34
0.090
 Why?
Syndrome
1
2011
333
0.090
 Why?
Risk Factors
5
2023
8634
0.090
 Why?
DNA-Binding Proteins
1
2017
1314
0.090
 Why?
Hospital Costs
1
2010
104
0.080
 Why?
Teratoma
1
2010
92
0.080
 Why?
Mycobacterium
1
2011
103
0.080
 Why?
Carcinoma, Papillary
1
2009
73
0.080
 Why?
Enzyme Inhibitors
1
2012
750
0.080
 Why?
Reoperation
2
2008
514
0.080
 Why?
Kaplan-Meier Estimate
2
2023
811
0.080
 Why?
Registries
1
2016
1768
0.080
 Why?
Transcription Factors
1
2017
1528
0.080
 Why?
Proto-Oncogene Proteins
1
2012
608
0.080
 Why?
Lymph Nodes
2
2023
419
0.080
 Why?
Stents
1
2012
475
0.080
 Why?
Time Factors
4
2023
6114
0.080
 Why?
Positron-Emission Tomography
2
2009
259
0.070
 Why?
Carcinoid Tumor
1
2008
25
0.070
 Why?
Mountaineering
1
2008
47
0.070
 Why?
Multivariate Analysis
3
2019
1430
0.070
 Why?
Spectral Karyotyping
1
2007
5
0.070
 Why?
Atrial Fibrillation
1
2011
322
0.070
 Why?
Li-Fraumeni Syndrome
1
2007
11
0.070
 Why?
Respiratory Sounds
1
2008
110
0.070
 Why?
Pyrimidines
1
2010
376
0.070
 Why?
Urinary Bladder Neoplasms
1
2009
196
0.070
 Why?
Surgical Flaps
1
2008
121
0.070
 Why?
Barrett Esophagus
1
2009
147
0.070
 Why?
Chromosome Aberrations
1
2007
134
0.070
 Why?
Sulfonamides
1
2010
445
0.070
 Why?
Decision Making
1
2013
782
0.070
 Why?
Fatigue
2
2023
294
0.070
 Why?
Carbonic Anhydrases
1
2006
13
0.070
 Why?
Delivery of Health Care
1
2013
833
0.060
 Why?
Hyaluronan Receptors
1
2006
90
0.060
 Why?
Precancerous Conditions
1
2007
158
0.060
 Why?
Kidney Neoplasms
1
2009
327
0.060
 Why?
Sialoglycoproteins
1
2006
159
0.060
 Why?
Neoplasm Recurrence, Local
3
2023
859
0.060
 Why?
Hospital Mortality
2
2019
776
0.060
 Why?
Radiotherapy, Adjuvant
1
2005
182
0.060
 Why?
Antineoplastic Agents
2
2012
1879
0.060
 Why?
Heart-Lung Transplantation
1
2004
9
0.060
 Why?
Antigens, Neoplasm
1
2006
222
0.060
 Why?
Chylothorax
1
2004
11
0.060
 Why?
Odds Ratio
2
2019
953
0.060
 Why?
Diagnosis, Differential
2
2010
1342
0.060
 Why?
Biomarkers, Tumor
2
2007
1040
0.060
 Why?
Apoptosis
1
2012
2363
0.050
 Why?
Cytogenetic Analysis
1
2003
29
0.050
 Why?
Contraindications
1
2003
85
0.050
 Why?
Evidence-Based Medicine
2
2017
668
0.050
 Why?
Lung
4
2024
3561
0.050
 Why?
Mesoderm
1
2003
138
0.050
 Why?
Advisory Committees
1
2023
208
0.050
 Why?
Sex Factors
1
2007
1715
0.050
 Why?
Airway Management
1
2022
60
0.050
 Why?
Cell Survival
2
2017
1021
0.050
 Why?
Oxygen
1
2006
854
0.050
 Why?
Induction Chemotherapy
1
2021
56
0.050
 Why?
Feasibility Studies
2
2015
737
0.050
 Why?
Learning Curve
1
2021
63
0.040
 Why?
Data Warehousing
1
2020
5
0.040
 Why?
Receptor Protein-Tyrosine Kinases
1
2022
226
0.040
 Why?
Gene Expression Regulation, Neoplastic
3
2012
1143
0.040
 Why?
Recurrence
1
2023
935
0.040
 Why?
Intermediate Care Facilities
1
2019
3
0.040
 Why?
Chemoradiotherapy
1
2021
188
0.040
 Why?
Margins of Excision
1
2019
29
0.040
 Why?
Survival Analysis
2
2017
1211
0.040
 Why?
Cytokines
1
2007
1841
0.040
 Why?
Imaging, Three-Dimensional
1
2003
512
0.040
 Why?
Guideline Adherence
1
2023
490
0.040
 Why?
Walk Test
1
2019
52
0.040
 Why?
Serum Albumin
1
2019
137
0.040
 Why?
Radiography, Thoracic
2
2010
150
0.040
 Why?
Sarcopenia
1
2019
63
0.040
 Why?
Algorithms
1
2005
1470
0.040
 Why?
Skilled Nursing Facilities
1
2019
121
0.040
 Why?
Incidence
1
2023
2314
0.040
 Why?
Lymphocyte Count
1
2017
133
0.040
 Why?
Continuity of Patient Care
1
2019
253
0.040
 Why?
NADPH Oxidase 4
1
2017
8
0.030
 Why?
Antigen-Presenting Cells
1
2017
150
0.030
 Why?
Regression Analysis
1
2019
945
0.030
 Why?
Glutathione Disulfide
1
2017
26
0.030
 Why?
Geography
1
2017
177
0.030
 Why?
Inflammation
1
2007
2480
0.030
 Why?
Gastric Emptying
1
2017
40
0.030
 Why?
Immunophenotyping
1
2017
274
0.030
 Why?
Home Care Services
1
2019
223
0.030
 Why?
Gastroepiploic Artery
1
2015
4
0.030
 Why?
Cytoplasm
1
2017
255
0.030
 Why?
Superoxides
1
2017
214
0.030
 Why?
Mammary Arteries
1
2015
6
0.030
 Why?
Writing
1
2017
82
0.030
 Why?
Clinical Protocols
1
2017
233
0.030
 Why?
Radial Artery
1
2015
66
0.030
 Why?
Green Fluorescent Proteins
1
2017
371
0.030
 Why?
Fluorescent Dyes
1
2017
301
0.030
 Why?
Tumor Microenvironment
1
2017
430
0.030
 Why?
Young Adult
3
2014
10471
0.030
 Why?
Adaptor Proteins, Signal Transducing
1
2017
367
0.030
 Why?
Oxidation-Reduction
1
2017
923
0.030
 Why?
Lymphocyte Activation
1
2017
1037
0.030
 Why?
Antioxidants
1
2017
530
0.030
 Why?
Analgesics, Opioid
1
2020
771
0.030
 Why?
Solid Phase Microextraction
1
2012
6
0.030
 Why?
Biomechanical Phenomena
1
2015
669
0.030
 Why?
Breath Tests
1
2012
82
0.030
 Why?
Gas Chromatography-Mass Spectrometry
1
2012
124
0.030
 Why?
Gastroscopy
1
2012
18
0.030
 Why?
Silicones
1
2012
20
0.030
 Why?
Fibroblasts
1
2017
838
0.020
 Why?
Cross-Sectional Studies
1
2022
4411
0.020
 Why?
Foreign-Body Migration
1
2012
37
0.020
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2012
157
0.020
 Why?
Gene Expression Profiling
2
2010
1518
0.020
 Why?
Proto-Oncogene Proteins p21(ras)
1
2012
228
0.020
 Why?
Lymphatic Metastasis
1
2012
275
0.020
 Why?
Adolescent
3
2014
17854
0.020
 Why?
Gene Expression Regulation, Enzymologic
1
2012
270
0.020
 Why?
Forced Expiratory Volume
1
2012
475
0.020
 Why?
Global Health
1
2013
287
0.020
 Why?
Device Removal
1
2012
126
0.020
 Why?
Debridement
1
2011
73
0.020
 Why?
Mice, Knockout
1
2017
2570
0.020
 Why?
Follow-Up Studies
1
2019
4411
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2012
923
0.020
 Why?
Air
1
2010
32
0.020
 Why?
Indazoles
1
2010
58
0.020
 Why?
Attitude of Health Personnel
1
2017
975
0.020
 Why?
Chest Pain
1
2010
81
0.020
 Why?
Blotting, Western
1
2012
1147
0.020
 Why?
Molecular Targeted Therapy
1
2012
347
0.020
 Why?
Diarrhea
1
2010
171
0.020
 Why?
Photochemotherapy
1
2009
29
0.020
 Why?
NF-kappa B
1
2012
641
0.020
 Why?
Cisplatin
1
2009
262
0.020
 Why?
Dose-Response Relationship, Drug
1
2012
1842
0.020
 Why?
Phosphorylation
1
2012
1569
0.020
 Why?
Suicide
1
2014
508
0.020
 Why?
Drug Administration Schedule
1
2010
718
0.020
 Why?
Pilot Projects
1
2012
1373
0.020
 Why?
Administration, Oral
1
2010
729
0.020
 Why?
Esophagoscopy
1
2009
184
0.020
 Why?
Gene Expression Regulation
1
2017
2320
0.020
 Why?
Biomarkers
1
2017
3408
0.020
 Why?
Decompression, Surgical
1
2008
93
0.020
 Why?
Carbonic Anhydrase IX
1
2006
3
0.020
 Why?
Population Surveillance
1
2009
392
0.020
 Why?
In Situ Hybridization, Fluorescence
1
2007
309
0.020
 Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2006
19
0.020
 Why?
Osteopontin
1
2006
32
0.020
 Why?
Catheter Ablation
1
2009
288
0.020
 Why?
Reproducibility of Results
1
2013
2766
0.020
 Why?
Tegafur
1
2005
3
0.020
 Why?
Platinum Compounds
1
2005
9
0.020
 Why?
Cell Line, Tumor
1
2012
2711
0.020
 Why?
Uracil
1
2005
28
0.020
 Why?
Biopsy
1
2009
1036
0.020
 Why?
Age Factors
1
2012
2894
0.020
 Why?
Drainage
1
2006
151
0.020
 Why?
RNA, Messenger
1
2012
2553
0.020
 Why?
Respiratory Mucosa
1
2007
251
0.020
 Why?
Meta-Analysis as Topic
1
2005
158
0.020
 Why?
Clone Cells
1
2005
247
0.010
 Why?
Neoplasm Invasiveness
1
2006
442
0.010
 Why?
Aminocaproates
1
2004
2
0.010
 Why?
Decision Trees
1
2004
81
0.010
 Why?
Oligonucleotide Array Sequence Analysis
1
2006
740
0.010
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2005
309
0.010
 Why?
Sensitivity and Specificity
1
2007
1695
0.010
 Why?
Hypertension
1
2010
1056
0.010
 Why?
Clinical Trials as Topic
1
2005
932
0.010
 Why?
Case-Control Studies
1
2007
3004
0.010
 Why?
Cells, Cultured
1
2007
3886
0.010
 Why?
Animals
1
2017
31710
0.010
 Why?
Mitchell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (370) concept(s)
_
Co-Authors Expand Description
See all (60) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)